National Infusion Center Association

“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients”  This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her […]

“Q&A: Monoclonal Antibodies for COVID-19” In this Q&A interview with Jason C. Gallagher, PharmD, Clinical Professor and Clinical Specialist at Temple University, NICA is mentioned as […]

“Experimental COVID-19 treatment aimed at keeping Ventura County residents out of hospitals” NICA President and CEO, Brian Nyquist, is quoted in this article expressing the importance […]

“Powerful New Tool Predicts COVID Trends” This article explores predictive analytics for predicting COVID-19 surges, and NICA is mentioned as one of the organizations helping to […]

“Lower valley hospital sees success with COVID-19 antibody treatments” This article explains how one local hospital in Sunnyside, Washington successful administered monoclonal antibodies to COVID-positive patients. […]

“NIH COVID-19 Treatment Guidelines Strongly Recommend Use of REGEN-COV™ (casirivimab with imdevimab) in Outpatients at High Risk of Clinical Progression” This article mentions that under the […]

“High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression Online Live CME Accredited Webinars” This article mentions NICA as a key resource for clinicians looking to […]

“COVID antibody treatments going unused in WA state as hospitals fill up, DOH says” As pandemic-related hospitalizations increase as a result of the Delta-variant of COVID-19, […]

By: Tiffani Bouchard, CCS Managing JW and JZ Modifiers When Billing Single-Dose Drugs Managing JW and JZ modifiers when billing single-dose drugs can be challenging. As […]